Hospital CEOs’ defense of higher facility-based charges before Congress is likely to sharpen site-of-care questions for San Diego physicians. However, the reviewed sources did not identify any immediate local billing or referral policy changes tied to the hearing.
Executives from HCA Healthcare, CommonSpirit Health, NewYork-Presbyterian, and ECU Health testified at an April 28 House Ways and Means Committee hearing, where lawmakers questioned hospital prices, consolidation, and site-neutral payment policy, according to the committee and news reports. Hospital executives defended their pricing practices, while the American Hospital Association said hospitals face significant cost pressures as they treat a sicker, more medically complex, and aging patient population.
The national pricing debate carries significant practical consequences for medical practices in San Diego. While physicians lack direct control over facility-fee policies, their referral patterns for specialty consults, imaging, infusions, procedures, and outpatient follow-up remain influential. As payers, employers, and patients increasingly examine hospital-based fees, medical groups will likely face heightened scrutiny of the safety and feasibility of transitioning services to more affordable ambulatory settings while maintaining standards for access, quality, and continuity of care.
House Ways and Means Committee Chair Jason Smith argued that hospital consolidation has contributed to rising costs. At the same time, Becker’s Hospital Review reported that hospital CEOs disputed lawmakers’ criticism and defended their pricing practices. The AHA, in a statement tied to the hearing, said hospitals are managing rising costs, workforce pressures, and financial strain while caring for more complex patients.
The issue may land differently depending on the practice model. Independent groups may see site-of-care scrutiny as an opportunity to emphasize lower-cost outpatient access. Hospital-employed physicians may face more patient questions about bills generated by hospital-affiliated sites. Specialists may need clearer internal guidance on when hospital outpatient departments are clinically justified, particularly for higher-risk patients, complex procedures, anesthesia needs, or services requiring immediate backup.
The operational takeaway is that site selection is becoming part of care navigation. San Diego physicians should expect continued pressure from payers, patients, and policymakers on hospital-based billing, facility fees, and site-neutral payment proposals. Rather than questioning the existence of facility fees, the focus has shifted toward determining clinical necessity for hospital settings versus ambulatory alternatives. Consequently, establishing clear and open dialogue with patients about these cost variations before treatment is delivered has become a critical objective.